![3D illustration of a Y-shaped molecule, purple and blue. This represents the antibody molecule.](https://www.embl.org/news/wp-content/uploads/2023/12/20221129_DeNov-AI-Biotech-300x180.jpeg)
Using artificial intelligence to discover therapeutic antibodies
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
SCIENCE & TECHNOLOGY2023
sciencescience-technology